A panel of advisors to the Indian government has recommended that late-stage clinical trials be waived under certain conditions for some new drugs already being sold on international markets. Indian law requires all medicines to be tested in late-stage clinical trials before being approved for sale. The recommendations were made last month at a meeting of the Drugs Technical Advisory Board, which advises the central and state governments on technical matters related to drug regulations. The 19-member panel agreed that clinical trials for new drugs already selling in a "well regulated country" may be waived, if the safety and efficacy of the drug is found to be "favorable", according to minutes of the meeting. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment